ONC FY 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

FY 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$1.2B+280.8% YoY

Gross Profit

$1.0B86.0% margin

Operating Income

-$1.4B-122.3% margin

Net Income

-$1.5B-123.9% margin

EPS (Diluted)

$-15.21

Cash Flow

Operating Cash Flow

-$1.3B

Free Cash Flow

-$1.6B

Stock-Based Comp.

$241M

Balance Sheet

Total Assets

$8.5B

Total Liabilities

$2.4B

Stockholders' Equity

$6.1B

Cash & Equivalents

$4.4B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$309M	+280.8%
Gross Profit	$1.0B	$238M	+324.6%
Operating Income	-$1.4B	-$1.7B	+13.2%
Net Income	-$1.5B	-$1.6B	+10.3%